SEC Form 4 · accession 0001140361-18-022661
RESMED INC · RMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gary W Pace
Director
Period of report
May 8, 2018
Accepted (ET)
May 10, 2018 · 7:07 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000943819
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| ResMed Common Stock | May 8, 2018 | M | 28,403 | $27.58 | A | 128,981 | D | |
| ResMed Common StockF1 | May 8, 2018 | S | 28,403 | $97.37 | D | 100,578 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ResMed Stock OptionsF2 | $27.58 | May 8, 2018 | M | 28,403 | D | Nov 11, 2014 | Nov 16, 2018 | ResMed Common Stock | 28,403 | 0 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $96.99 to $97.87. The price reported above reflects the weighted average sale price.
- F2Represents date options first became exercisable.